Restoring C-Section Babies’ Microbiota

A small pilot study suggests exposure to maternal vaginal fluids could restore infant microbiota following Cesarean-section delivery.

Written byCatherine Offord
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, ERNEST FBabies born by Cesarean section (C-section) are not always exposed to bacteria and other microbes present in the birth canals of their mothers, a factor that some studies have linked to potential health risks later in life. Now, researchers have presented preliminary data suggesting that microbial communities could be at least partly restored by swabbing C-section–delivered babies with their mothers’ vaginal fluids immediately after birth. The results appeared today (February 1) in Nature Medicine.

“Despite the small number of subjects, our study shows significant differences in the bacterial communities of C-section infants exposed to the maternal vaginal fluid, whose microbiota is partially restored and more similar to that of vaginally delivered infants,” study coauthor Jose Clemente, an assistant professor at Icahn School of Medicine at Mount Sinai in New York City, told reporters during a press briefing.

Considered medically necessary in just 10 percent to 15 percent of births, C-sections are used to deliver approximately one in three babies born in the U.S., according to the Centers for Disease Control and Prevention. The practice carries considerable risks for mothers, including the possibility of medical complications such as unplanned hysterectomies and ruptured uteruses.

C-sections also pose risks to the infants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies